AlzeCure Pharma AB's total assets for Q3 2025 were kr66.59M, an increase of 306.19% from the previous quarter. DE:AC6 total liabilities were kr15.93M for the fiscal quarter, a 58.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.